China's Health Ministry: Fujifilm’s anti-flu drug effective in treating coronavirus

Zhang Xinmin, an official at Red china'southward science and applied science ministry, announced that favipiravir, also known every bit Avigan developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 coronavirus patients. Avigan is an experimental antiviral used to treat RNA viruses, which has shown efficacy against flu derivatives, yellow fever, foot-and-mouth disease and numerous others. It has also shown an effect against Ebola and Zika virus, and contempo clinical trials take demonstrated its efficacy against the novel coronavirus.

Addressing the media, Xinmin said, "It has a high degree of safety and is effective in treatment." Co-ordinate to reports, Japanese doctors are using this drug in clinical studies on coronavirus patients with balmy to moderate symptoms and hoping information technology will prevent the virus from multiplying in patients. However, a Japanese wellness ministry source also mentioned that the drug was not every bit effective in people with more severe symptoms. "We've given Avigan to 70 to fourscore people, but it doesn't seem to work that well when the virus has already multiplied," the source added.

As reported by China's public wellness broadcaster NHK, patients who were given the medicine in Shenzhen turned negative for the virus afterwards a median of 4 days after becoming positive, while those who were non given this drug experienced a median of 11 days. Similarly, X-rays reports also confirmed improvements in lung condition in virtually 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.

Avigan, which was initially intended to treat flu, would need authorities approval for full-scale use on coronavirus patients. A health official as well stated that the drug could be approved as early every bit May. All the same, approval is besides linked to the success of the duration of clinical trials. If the results of clinical research are delayed, the approval could also exist delayed.

Shares in Japanese firm Fujifilm Holding surged 15% on Wednesday after Chinese regime said that the drug produced by the company could exist effective for treating Covid – 19 patients.

As you bring together us today from India and elsewhere, nosotros have a favour to enquire. Through these times of ambiguity and challenge, the packaging industry in Bharat and in nigh parts of the world has been fortunate. Nosotros are now read in more than 90 countries equally our coverage widens and increases in bear upon. Our traffic as per analytics more than doubled in 2022 and many readers chose to support us financially even when advertizing fell to pieces.

As we come out of the pandemic in the next few months, we hope to over again expand our geography and evolve our high-impact reporting and administrative and technical information, with some of the best correspondents in the industry. If there were ever a time to support us, information technology is at present. You can ability Packaging South Asia's balanced industry journalism and help to sustain united states of america by subscribing.

Subscribe Now

everettsernis.blogspot.com

Source: https://packagingsouthasia.com/type-of-article/industry-news/fujifilms-anti-flu-drug-effective-in-treating-coronavirus/

Share this post